Good morning :)
$
₹
Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

LKFT

NASDAQ
$33.420.41% (-0.14)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Mid Cap

With a market cap of $2.2B the stock is ranked 2086

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

3.24
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.58
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$10.52
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

60.23%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 6 analysts reports

Buy
2 analysts
Hold
3 analysts
Sell
1 analyst

Price Upside

-8.68%

Earnings Growth

-105.85%

Rev. Growth

-89.46%

See Detailed Forecast

Company Profile

Company Profile

P/E Ratio
50.65
50.65
1Y Return
31.59%
31.59%
Buy Reco %
79.31
79.31
P/E Ratio
27.73
27.73
1Y Return
46.88%
46.88%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
35.24%
35.24%
Buy Reco %
78.57
78.57
P/E Ratio
35.33
35.33
1Y Return
31.43%
31.43%
Buy Reco %
81.25
81.25
P/E Ratio
—
—
1Y Return
944.75%
944.75%
Buy Reco %
17.39
17.39
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Financials

Financials

Income

Balance Sheet

Cash Flow

71.1
-202.1
900.8
782.1
6.4
14.4
12.1
2.1
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue62.4377.8759.8475.4974.9765.2871.16900.826.4812.11
Net Income90.228.98-50.4325.30-153.40-105.74-202.11782.1414.492.10
Net Profit Margin144.50%11.53%-84.26%33.52%-204.60%-161.97%-284.01%86.82%223.60%17.39%

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Lakefront Biotherapeutics NV 3.240.58-
AbbVie Inc50.6550.450.58
Amgen Inc27.7321.332.75

Price Comparison

Price Comparison

Compare LKFT with any stock or ETF
Compare LKFT with any stock or ETF
Comparing from
LKFT
ABBV
AMGN
Loading...

Frequently asked questions

  1. Lakefront Biotherapeutics NV (LKFT) share price today is $33.42 as of November 7, 2026 at 2:29 AM IST. The stock touched a day high of $33.58 and a day low of $32.43.

  2. Lakefront Biotherapeutics NV stock trades on NASDAQ under the ticker symbol LKFT.

  3. Lakefront Biotherapeutics NV's market capitalization is $2.24B as of November 7, 2026 at 2:29 AM IST.

  4. Lakefront Biotherapeutics NV's price-to-earnings (P/E) ratio is 3.24 as of November 6, 2026.

  5. Lakefront Biotherapeutics NV's price-to-book (P/B) ratio is 0.58 as of November 6, 2026.

  6. Yes, You can buy Lakefront Biotherapeutics NV shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Lakefront Biotherapeutics NV shares in three steps: 1. Search Lakefront Biotherapeutics NV on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Lakefront Biotherapeutics NV trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Lakefront Biotherapeutics NV (LKFT) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.2992 shares at the current price of $33.42.

Loading...